Skip to main content
About Us
About Arcus
Leadership
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Contact Us
Pipeline
Clinical Pipeline
Etrumadenant
AB680
Domvanalimab
Zimberelimab
Discovery Pipeline
Clinical Trials
Overview
Prostate Cancer
Colorectal Cancer
Lung Cancer
Pancreatic Cancer
Multiple Cancer Types
Expanded Access Program
Publications
Careers
Investors & Media
Press Releases
Events & Presentations
Events Calendar
Corporate Presentation
Stock Information
Analyst Coverage
Stock Information
SEC Filings
Corporate Governance
Governance Documents
Management Team
Board of Directors
Committee Composition
Contact Investor Relations
Contact Investor Relations
FAQs
Email Alerts
Analyst Coverage
About Us
About Arcus
Leadership
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Contact Us
Pipeline
Clinical Pipeline
Etrumadenant
AB680
Domvanalimab
Zimberelimab
Discovery Pipeline
Clinical Trials
Overview
Prostate Cancer
Colorectal Cancer
Lung Cancer
Pancreatic Cancer
Multiple Cancer Types
Expanded Access Program
Publications
Careers
Investors & Media
Press Releases
Events & Presentations
Events Calendar
Corporate Presentation
Stock Information
Analyst Coverage
Stock Information
SEC Filings
Corporate Governance
Governance Documents
Management Team
Board of Directors
Committee Composition
Contact Investor Relations
Contact Investor Relations
FAQs
Email Alerts
Firm
Analyst
Barclays
Peter Lawson, DPhil (Oxon)
Berenberg
Zhiqiang Shu, PhD
BTIG
Thomas Shrader, PhD, CFA
Cantor Fitzgerald
Alethia Young
Citi
Yigal Nochomovitz, PhD
Evercore ISI
Umer Raffat
Goldman Sachs
Salveen Richter
Leerink
Geoffrey C. Porges, MBBS
Mizuho
Mara Goldstein
Truist
Robyn Karnauskas, PhD
Wedbush
Robert Driscoll, PhD
Arcus Biosciences is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Arcus Biosciences’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Arcus Biosciences or its management. Arcus Biosciences does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.